BOI Bank Irel13.375

RNS Number:4580Z
Biotrace International PLC
08 March 2006



For Immediate Release                                             8 March 2006

                           BIOTRACE INTERNATIONAL PLC

                         Purchase of Target Diagnostica

Biotrace International Plc ("Biotrace", "the Company" or "the Group"), a leading
manufacturer of industrial microbiology products, announces today that it has
purchased the remaining shares in Target Diagnostica srl ("Target") for
approximately #0.3 million in cash.

The MicroSafe Group ("MicroSafe") based in Italy, was acquired by Biotrace in
September 2005 and held 39% of Target. MicroSafe has now acquired the remaining
61% of Target's shares. Based in Milan, Target distributes microbiology
products, principally to the food, environmental and pharmaceutical industries
and has worked closely with MicroSafe for a number of years. Target had revenues
of Euro2 million (approximately #1.4 million) in 2005 and a pre tax profit of Euro0.2
million (approximately #0.1 million). The consideration for the remaining shares
will be satisfied by way of cash amounting to Euro0.5 million (approximately #0.3
million) which will be paid in two equal payments in January 2007 and January
2008. These payments bring the total consideration for Target to Euro0.8 million
(approximately #0.5 million).

Highlights

   * Adds approximately #1.4 million to Group revenues in a full year

   * Immediately earnings enhancing with approximately #0.1 million of profit
     in a full year

   * Strong recurring revenues from reagents and consumables

   * Enhances competitive position and provides opportunity for improved
     efficiencies

Ian Johnson, Chief Executive Officer of Biotrace, said:

"With this latest addition to the Group, Biotrace is continuing to strengthen
its position in Europe as a leading manufacturer and supplier of microbiology
products to the industrial market. The completion of the purchase of Target and
its integration within MicroSafe will provide an opportunity to improve the
financial performance of the Group. Mr Veronesi, the founder and Managing
Director of Target has together with his team, developed a strong position in
the Italian market and I look forward to building on his achievements."

                                    - ENDS -
For further information, please contact:

Biotrace International Plc
Ian Johnson, Chief Executive Officer                   Tel : +44 (0)1656 641 400
Peter Morgan, Finance Director

Buchanan Communications
Tim Anderson / James Strong                            Tel: +44 (0)20 7466 5000

Notes to editors:

Biotrace International Plc is a leading manufacturer and supplier of industrial
microbiology products. The Company is organised into three business segments:
Food & Environmental, Pharmaceutical, Personal Care & Cosmetics and Defence. The
Group's proprietary technologies are used by most of the world's leading food
and beverage manufacturers who rely on Biotrace products as an essential part of
their quality control procedures. Other industrial customers include
pharmaceutical and personal care product/cosmetics manufacturers together with
environmental/industrial process water clients. The Defence segment provides
systems and consumables for the rapid detection of biological weapons for
military and homeland security organisations.

Formed in 1988 and floated on the London Stock Exchange in 1993, Biotrace had
total revenues of over #29 million in 2005. The Company is headquartered in
Bridgend, UK with manufacturing and sales operations worldwide. Visit Biotrace
at www.biotrace.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
ACQILFLTVVIDIIR

Bank Irel13.375 (LSE:BOI)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024

Bank Irel13.375 (LSE:BOI)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024